...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: How & who comes up with valuations?

Are the numbers derived from what they feel the fair market value of company is at the time the PP's  etc etc are done? Who decides that & is there any oversight etc?

they seem cheap, almost like gifts to the insiders etc participating. 

Would people doing this be privileged with/to more information than what we see or do they only know/see the same information that we have been presented with?

I just don't understand how they could be privey to insider information that we are not should that be the case?

Share
New Message
Please login to post a reply